메뉴 건너뛰기




Volumn 19, Issue 5, 2013, Pages 471-482

Venous thromboembolism in women: A specific reproductive health risk

Author keywords

Hormonal contraception; Hormone replacement therapy; Ovarian hyperstimulation; Pregnancy; Venous thromboembolism

Indexed keywords

DESOGESTREL; DROSPIRENONE; GESTODENE; LEVONORGESTREL;

EID: 84882735270     PISSN: 13554786     EISSN: 14602369     Source Type: Journal    
DOI: 10.1093/humupd/dmt028     Document Type: Article
Times cited : (73)

References (99)
  • 1
    • 0037341535 scopus 로고    scopus 로고
    • Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use
    • Abdollahi M, Cushman M, Rosendaal FR. Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use. Thromb Haemost 2003;89:493-498.
    • (2003) Thromb Haemost , vol.89 , pp. 493-498
    • Abdollahi, M.1    Cushman, M.2    Rosendaal, F.R.3
  • 2
  • 3
    • 84555170228 scopus 로고    scopus 로고
    • Obesity and venous thrombosis: a review
    • Allman-Farinelli MA. Obesity and venous thrombosis: a review. Semin Thromb Hemost 2011;8:903-907.
    • (2011) Semin Thromb Hemost , vol.8 , pp. 903-907
    • Allman-Farinelli, M.A.1
  • 5
    • 52649137538 scopus 로고    scopus 로고
    • Virchowand his triad: a question of attribution
    • Bagot CN, Arya R. Virchowand his triad: a question of attribution. Br J Haematol 2008; 143:180-190.
    • (2008) Br J Haematol , vol.143 , pp. 180-190
    • Bagot, C.N.1    Arya, R.2
  • 6
    • 84856809942 scopus 로고    scopus 로고
    • Antithrombotic therapy and prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-based Clinical Practice Guidelines
    • VTE, thrombophilia, antithrombotic therapy and pregnancy
    • Bates SM, Greer IA, Middeldorp S, Veenstra DL, Prabulos AM, Vandvick PO. VTE, thrombophilia, antithrombotic therapy and pregnancy. Antithrombotic therapy and prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-based Clinical Practice Guidelines. Chest 2012;141:e691S-e736S.
    • (2012) Chest , vol.141
    • Bates, S.M.1    Greer, I.A.2    Middeldorp, S.3    Veenstra, D.L.4    Prabulos, A.M.5    Vandvick, P.O.6
  • 8
    • 84873396245 scopus 로고    scopus 로고
    • Risk of venous thromboembolism in women with polycystic ovary syndrome: a population-based matched cohort analysis
    • Bird ST, Hartzema AG, Brophy JM, Etminan M, Delaney JA. Risk of venous thromboembolism in women with polycystic ovary syndrome: a population-based matched cohort analysis. CMAJ 2013;185:E115-E120.
    • (2013) CMAJ , vol.185
    • Bird, S.T.1    Hartzema, A.G.2    Brophy, J.M.3    Etminan, M.4    Delaney, J.A.5
  • 10
    • 73949103286 scopus 로고    scopus 로고
    • The hemostatic system through aging and menopause
    • Bucciarelli P, Mannucci PM. The hemostatic system through aging and menopause. Climacteric 2009;12(Suppl. 1):47-51.
    • (2009) Climacteric , vol.12 , Issue.SUPPL. 1 , pp. 47-51
    • Bucciarelli, P.1    Mannucci, P.M.2
  • 11
    • 67650312805 scopus 로고    scopus 로고
    • The 'ART' of thrombosis: a review of arterial and venous thrombosis in assisted reproductive technology
    • Chan WS. The 'ART' of thrombosis: a review of arterial and venous thrombosis in assisted reproductive technology. Curr Opin Obstet Gynecol 2009;21:207-218.
    • (2009) Curr Opin Obstet Gynecol , vol.21 , pp. 207-218
    • Chan, W.S.1
  • 12
    • 41749083767 scopus 로고    scopus 로고
    • The 'ART' of thromboembolism: a review of assisted reproductive technology and thromboembolic complications
    • Chan WS, Dixon ME. The 'ART' of thromboembolism: a review of assisted reproductive technology and thromboembolic complications. Thromb Res 2008; 121:713-726.
    • (2008) Thromb Res , vol.121 , pp. 713-726
    • Chan, W.S.1    Dixon, M.E.2
  • 13
    • 51649098569 scopus 로고    scopus 로고
    • Guidelines for computed tomography and magnetic resonance imaging use during pregnancy and lactation
    • Chen MM, Coakley FV, Kamal A, Loros RK Jr. Guidelines for computed tomography and magnetic resonance imaging use during pregnancy and lactation. Obstet Gynecol 2008;112(2 Pt 1):333-340.
    • (2008) Obstet Gynecol , vol.112 , Issue.2 PART 1 , pp. 333-340
    • Chen, M.M.1    Coakley, F.V.2    Kamal, A.3    Loros, R.K.4
  • 16
    • 0013351714 scopus 로고    scopus 로고
    • Cypoterone acetate (Dianette): risk of venous thromboembolism (VTE)
    • CSM.
    • CSM. Cypoterone acetate (Dianette): risk of venous thromboembolism (VTE). Curr Prob Pharmacovigil 2002;28:9-10.
    • (2002) Curr Prob Pharmacovigil , vol.28 , pp. 9-10
  • 17
    • 78649233245 scopus 로고    scopus 로고
    • O varian hyperstimulationsyndrome prevention strategies: cryopreservation of all embryos
    • D'AngeloA. Ovarian hyperstimulationsyndrome prevention strategies: cryopreservation of all embryos. Semin Reprod Med 2010;28:513-518.
    • (2010) Semin Reprod Med , vol.28 , pp. 513-518
    • D'Angelo, A.1
  • 18
    • 33749266340 scopus 로고    scopus 로고
    • The risk of recurrent venous thromboembolism in pregnancy and puerperium withoUT antithrombotic prophylaxis
    • DeStefanoV, Martinelli I, Rossi E, BattaglioliT, Za T, Mannucci PM, Leone G. The risk of recurrent venous thromboembolism in pregnancy and puerperium withoUT antithrombotic prophylaxis. Br J Haematol 2006;135:386-391.
    • (2006) Br J Haematol , vol.135 , pp. 386-391
    • DeStefano, V.1    Martinelli, I.2    Rossi, E.3    Battaglioli, T.4    Za, T.5    Mannucci, P.M.6    Leone, G.7
  • 19
    • 34047263992 scopus 로고    scopus 로고
    • The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance study on Oral Contraceptives based on 142,475 women-years of observation
    • Dinger JC, Heinemann LAJ, Kuhl-Habich D. The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance study on Oral Contraceptives based on 142,475 women-years of observation. Contraception 2007;75:344-354.
    • (2007) Contraception , vol.75 , pp. 344-354
    • Dinger, J.C.1    Heinemann, L.A.J.2    Kuhl-Habich, D.3
  • 20
    • 0036181630 scopus 로고    scopus 로고
    • Metabolic effects of implantable steroid contraceptives for women
    • Dorflinger LJ. Metabolic effects of implantable steroid contraceptives for women. Contraception 2002;65:47-62.
    • (2002) Contraception , vol.65 , pp. 47-62
    • Dorflinger, L.J.1
  • 24
    • 84882610740 scopus 로고    scopus 로고
    • European Medicines Agency. EMA update on Diane 35 (cyproterone acetate 2mg, ethinylestradiol 35mcg) and generics for treatment of acne following French decision to suspend marketing authorization, January 2013
    • European Medicines Agency. EMA update on Diane 35 (cyproterone acetate 2mg, ethinylestradiol 35mcg) and generics for treatment of acne following French decision to suspend marketing authorization, January 2013. http://www.ema. europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/01/news_ detail_001703.jsp&mid=WC0b01ac058004d5c1.
  • 25
    • 84882613633 scopus 로고    scopus 로고
    • FDA, U.S
    • FDA, U.S. Food and Drug Administration, 2011. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm273 039.htm.
    • (2011) Food and Drug Administration
  • 26
    • 0035822254 scopus 로고    scopus 로고
    • Adjusting Europe's drug regulation to public health needs
    • Garattini S, Bertele V. Adjusting Europe's drug regulation to public health needs. Lancet 2002;358:64-67.
    • (2001) Lancet , vol.358 , pp. 64-67
    • Garattini, S.1    Bertele, V.2
  • 27
    • 84860835430 scopus 로고    scopus 로고
    • Pulmonary embolism and deep vein thrombosis
    • Goldhaber SZ, Bounameaux H. Pulmonary embolism and deep vein thrombosis. Lancet 2012;379:1835-1846.
    • (2012) Lancet , vol.379 , pp. 1835-1846
    • Goldhaber, S.Z.1    Bounameaux, H.2
  • 28
    • 34249751711 scopus 로고    scopus 로고
    • Effect of depomedroxyprogesterone acetate on coagulation parameter: a pilot study
    • Goldstein J, Cushman M, Badger GJ, Johnson JV. Effect of depomedroxyprogesterone acetate on coagulation parameter: a pilot study. Fertil Steril 2007;87:1267-1270.
    • (2007) Fertil Steril , vol.87 , pp. 1267-1270
    • Goldstein, J.1    Cushman, M.2    Badger, G.J.3    Johnson, J.V.4
  • 29
    • 27644460334 scopus 로고    scopus 로고
    • Systematic review and meta-analysis of the diagnostic accuracy of ultrasonography for deep vein thrombosis
    • Goodacre S, Sampson F, Thomas S, van Beek E, Sutton A. Systematic review and meta-analysis of the diagnostic accuracy of ultrasonography for deep vein thrombosis. BMC Med Imaging 2005;5:6.
    • (2005) BMC Med Imaging , vol.5 , pp. 6
    • Goodacre, S.1    Sampson, F.2    Thomas, S.3    van Beek, E.4    Sutton, A.5
  • 30
    • 84856373752 scopus 로고    scopus 로고
    • The progestogen content of combined oral contraceptives and venous thromboembolic risk
    • Hannaford PC. The progestogen content of combined oral contraceptives and venous thromboembolic risk. BMJ 2011;343:d6592.
    • (2011) BMJ , vol.343
    • Hannaford, P.C.1
  • 31
    • 84860168391 scopus 로고    scopus 로고
    • No evidence that assisted reproduction increases the risk of thrombosis: a Danish national cohort study
    • Hansen AT, Kesmodel US, Juul S, Hvas AM. No evidence that assisted reproduction increases the risk of thrombosis: a Danish national cohort study. Hum Reprod 2012;27:1499-1503.
    • (2012) Hum Reprod , vol.27 , pp. 1499-1503
    • Hansen, A.T.1    Kesmodel, U.S.2    Juul, S.3    Hvas, A.M.4
  • 32
    • 0033028689 scopus 로고    scopus 로고
    • Oral progestogen-only contraceptives and cardiovascular risk: results from the Transnational Study on Oral Contraceptives and the Health of Young Women
    • Heinemann LA, Assmann A, DoMinh T, Garbe E. Oral progestogen-only contraceptives and cardiovascular risk: results from the Transnational Study on Oral Contraceptives and the Health of Young Women. Eur J Contracept Reprod Health Care 1999;4:67-73.
    • (1999) Eur J Contracept Reprod Health Care , vol.4 , pp. 67-73
    • Heinemann, L.A.1    Assmann, A.2    DoMinh, T.3    Garbe, E.4
  • 33
    • 32544431531 scopus 로고    scopus 로고
    • The epidemiology of venous thromboembolism in the community: implications for prevention and management
    • Heit JA. The epidemiology of venous thromboembolism in the community: implications for prevention and management. J Thromb Thrombolysis 2006;21: 23-29.
    • (2006) J Thromb Thrombolysis , vol.21 , pp. 23-29
    • Heit, J.A.1
  • 34
    • 28044439149 scopus 로고    scopus 로고
    • Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study
    • Heit JA, Kobbervig CE, James AH, Petterson TM, Bailey KR, Melton LJ III. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med 2005;143:697-706.
    • (2005) Ann Intern Med , vol.143 , pp. 697-706
    • Heit, J.A.1    Kobbervig, C.E.2    James, A.H.3    Petterson, T.M.4    Bailey, K.R.5    Melton, L.J.6
  • 35
    • 0037393051 scopus 로고    scopus 로고
    • Hemostasis during normal pregnancy and puerperium
    • Hellgren M. Hemostasis during normal pregnancy and puerperium. Semin Thromb Hemost 2003;29:125-130.
    • (2003) Semin Thromb Hemost , vol.29 , pp. 125-130
    • Hellgren, M.1
  • 36
    • 84873036155 scopus 로고    scopus 로고
    • Incidence of pulmonary and venous thromboembolism in pregnancies after in vitro fertilisation: cross sectional study
    • Henriksson P, Westerlund E, Wallen H, Brandt L, Hovatta O, Ekbom A. Incidence of pulmonary and venous thromboembolism in pregnancies after in vitro fertilisation: cross sectional study. BMJ 2013;346:e8632.
    • (2013) BMJ , vol.346
    • Henriksson, P.1    Westerlund, E.2    Wallen, H.3    Brandt, L.4    Hovatta, O.5    Ekbom, A.6
  • 37
    • 0034533428 scopus 로고    scopus 로고
    • Increased risk of recurrent venous thromboembolism during hormone replacement therapy-results of the randomized, double-blind, placebocontrolled estrogen in venous thromboembolism trial (EVTET)
    • Hoibraaten E, Qvigstad E, Arnesen H, Larsen S, Wickstrom E, Sandset PM. Increased risk of recurrent venous thromboembolism during hormone replacement therapy-results of the randomized, double-blind, placebocontrolled estrogen in venous thromboembolism trial (EVTET). Thromb Haemost 2000;84:961-967.
    • (2000) Thromb Haemost , vol.84 , pp. 961-967
    • Hoibraaten, E.1    Qvigstad, E.2    Arnesen, H.3    Larsen, S.4    Wickstrom, E.5    Sandset, P.M.6
  • 38
    • 0014962032 scopus 로고
    • ICSI (Institute for Clinical Systems Improvement).
    • (10 May 2012, date last accessed). Inman WH, VesseyMP, Westerholm B, Engelund A. Thromboembolic disease and the steroidal content of oral contraceptives. A report to the Committee on Safety of Drugs. BMJ
    • ICSI (Institute for Clinical Systems Improvement). http://www.icsi.org/knowledge/detail.asp?catID=29&itemID=202 (10 May 2012, date last accessed). Inman WH, VesseyMP, Westerholm B, Engelund A. Thromboembolic disease and the steroidal content of oral contraceptives. A report to the Committee on Safety of Drugs. BMJ 1970;2:203-209.
    • (1970) , vol.2 , pp. 203-209
  • 39
    • 43749117523 scopus 로고    scopus 로고
    • Ante- and postnatal risk factors of venous thrombosis: a hospital-based case-control study
    • Jacobsen AF, Skjeldestad FE, Sandset PM. Ante- and postnatal risk factors of venous thrombosis: a hospital-based case-control study. J Thromb Haemost 2008; 6:905-912.
    • (2008) J Thromb Haemost , vol.6 , pp. 905-912
    • Jacobsen, A.F.1    Skjeldestad, F.E.2    Sandset, P.M.3
  • 40
    • 46349106976 scopus 로고    scopus 로고
    • An overview of venous thromboembolism: impact, risks, and issues in prophylaxis
    • Jaffer AK. An overview of venous thromboembolism: impact, risks, and issues in prophylaxis. Cleve Clin J Med 2008;75(Suppl. 3):S3-S6.
    • (2008) Cleve Clin J Med , vol.75 , Issue.SUPPL. 3
    • Jaffer, A.K.1
  • 41
    • 33646117733 scopus 로고    scopus 로고
    • Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality
    • James AH, Jamison MG, Brancazio LR, Myers ER. Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am J Obstet Gynecol 2006;194:1311-1315.
    • (2006) Am J Obstet Gynecol , vol.194 , pp. 1311-1315
    • James, A.H.1    Jamison, M.G.2    Brancazio, L.R.3    Myers, E.R.4
  • 42
    • 84866135244 scopus 로고    scopus 로고
    • Elevation in D-dimer concentrations is positively correlated with gestation in normal uncomplicated pregnancy
    • JeremiahZA, Adias TC, Opiah M, George SP, MgbereO, Essien EJ. Elevation in D-dimer concentrations is positively correlated with gestation in normal uncomplicated pregnancy. Int J Womens Health 2012;4:437-443.
    • (2012) Int J Womens Health , vol.4 , pp. 437-443
    • Jeremiah, Z.A.1    Adias, T.C.2    Opiah, M.3    George, S.P.4    Mgbere, O.5    Essien, E.J.6
  • 43
    • 0034638671 scopus 로고    scopus 로고
    • Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995: cohort and case- control analysis
    • Jick H, Kaye JA, Vasilakis-Scaramozza C, Jick SS. Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995: cohort and case- control analysis. BMJ 2000;321:1190-1195.
    • (2000) BMJ , vol.321 , pp. 1190-1195
    • Jick, H.1    Kaye, J.A.2    Vasilakis-Scaramozza, C.3    Jick, S.S.4
  • 46
    • 84882640078 scopus 로고    scopus 로고
    • aringins on two birth control pills are too weak, FDA panel rules
    • Lenzer J. Waringins on two birth control pills are too weak, FDA panel rules. BMJ 2011; 343:1227.
    • (2011) BMJ , vol.343 , pp. 1227
    • Lenzer, J.W.1
  • 47
    • 69949088549 scopus 로고    scopus 로고
    • Hormonal contraception and risk of venous thromboembolism: national follow-up study
    • Lidegaard O, Loøkkegaard E, Svendsen AL, Agger C. Hormonal contraception and risk of venous thromboembolism: national follow-up study. BMJ 2009;339:b2890.
    • (2009) BMJ , vol.339
    • Lidegaard, O.1    Loøkkegaard, E.2    Svendsen, A.L.3    Agger, C.4
  • 48
    • 83655195179 scopus 로고    scopus 로고
    • Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9
    • Lidegaard O, Nielsen LH, Skovlund CV, Skjeldestad FE, Loøkkegaard E. Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9. BMJ 2011; 343:d6423.
    • (2011) BMJ , vol.343
    • Lidegaard, O.1    Nielsen, L.H.2    Skovlund, C.V.3    Skjeldestad, F.E.4    Loøkkegaard, E.5
  • 50
    • 84862897224 scopus 로고    scopus 로고
    • Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10
    • Lidegaard O, Nielsen LH, SkovlundCW, Loøkkegaard E. Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10. BMJ 2012b; 344:e2990.
    • (2012) BMJ , vol.344
    • Lidegaard, O.1    Nielsen, L.H.2    Skovlund, C.W.3    Loøkkegaard, E.4
  • 51
    • 80051576987 scopus 로고    scopus 로고
    • Is obstetric thromboprophylaxis with low-molecular-weight heparin effective? Yes, if administered properly
    • Lindqvist PG, Hellgren M. Is obstetric thromboprophylaxis with low-molecular-weight heparin effective? Yes, if administered properly. J Thromb Haemost 2011; 9:1669-1670.
    • (2011) J Thromb Haemost , vol.9 , pp. 1669-1670
    • Lindqvist, P.G.1    Hellgren, M.2
  • 52
    • 0030860570 scopus 로고    scopus 로고
    • Epidemiology of coagulation factors, inhibitors and activation markers: the Third Glasgow MONICA Survey. I. Illustrative reference ranges by age, sex and hormone use
    • Lowe GD, Rumley A, Woodward M, Morrison CE, Philippou H, Lane DA, Tunstall-Pedoe H. Epidemiology of coagulation factors, inhibitors and activation markers: the Third Glasgow MONICA Survey. I. Illustrative reference ranges by age, sex and hormone use. Br J Haematol 1997;97:775-784.
    • (1997) Br J Haematol , vol.97 , pp. 775-784
    • Lowe, G.D.1    Rumley, A.2    Woodward, M.3    Morrison, C.E.4    Philippou, H.5    Lane, D.A.6    Tunstall-Pedoe, H.7
  • 53
    • 84865724931 scopus 로고    scopus 로고
    • Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis
    • Mantha S, Karp R, Raghavan V, Terrin N, Bauer KA, Zwicker JI. Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis. BMJ 2012;345:e4944.
    • (2012) BMJ , vol.345
    • Mantha, S.1    Karp, R.2    Raghavan, V.3    Terrin, N.4    Bauer, K.A.5    Zwicker, J.I.6
  • 55
    • 0028574279 scopus 로고
    • Progestin-only oral contraception: a comprehensive review
    • McCann MF, Potter LS. Progestin-only oral contraception: a comprehensive review. Contraception 1994;50(Suppl. 1):S1-195.
    • (1994) Contraception , vol.50 , Issue.SUPPL. 1
    • McCann, M.F.1    Potter, L.S.2
  • 56
    • 84882582196 scopus 로고    scopus 로고
    • Medicines and Healthcare Products Regulatory Agency.
    • Updated advice. Drug Safety Update
    • Medicines and Healthcare Products Regulatory Agency. Hormone replacement therapy. Updated advice. Drug Safety Update 2007;1:2-6.
    • (2007) Hormone replacement therapy , vol.1 , pp. 2-6
  • 57
    • 0032945755 scopus 로고    scopus 로고
    • Die Inzidenz von Lungenembolien bei venosen Thrombosen
    • Mostbeck A. Die Inzidenz von Lungenembolien bei venosen Thrombosen. Wien Med Wochenschr 1999;149:72-75.
    • (1999) Wien Med Wochenschr , vol.149 , pp. 72-75
    • Mostbeck, A.1
  • 60
    • 59449086093 scopus 로고    scopus 로고
    • Prophylaxis of VTE in women-during assisted reproductive techniques
    • Nelson SM. Prophylaxis of VTE in women-during assisted reproductive techniques. Thromb Res 2009;123(Suppl. 3):S8-S15.
    • (2009) Thromb Res , vol.123 , Issue.SUPPL. 3
    • Nelson, S.M.1
  • 61
    • 84882729174 scopus 로고    scopus 로고
    • Venousthromboembolic diseases: the management of venous thromboembolic diseases and the role of thrombophilia testing; NICE Clinical Guideline
    • NICE (National Institute on Clinical Excellence) (26 February 2013, date last accessed).
    • NICE (National Institute on Clinical Excellence). Venousthromboembolic diseases: the management of venous thromboembolic diseases and the role of thrombophilia testing; NICE Clinical Guideline No. 144. http://www.nice.org.uk/nicemedia/live/13767/59711/59711.pdf (26 February 2013, date last accessed).
    • , vol.144
  • 62
    • 0026764834 scopus 로고
    • A prospective study of the incidence of deep-vein thrombosis within a defined urban population
    • Nordstrom M, Lindblad B, Bergqvist D, Kjellstrom T. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med 1992;232:155-160.
    • (1992) J Intern Med , vol.232 , pp. 155-160
    • Nordstrom, M.1    Lindblad, B.2    Bergqvist, D.3    Kjellstrom, T.4
  • 63
    • 84868095303 scopus 로고    scopus 로고
    • Is polycystic ovary syndrome another risk factor for venous thromboembolism? United States, 2003-2008
    • e8
    • Okoroh EM, Hooper WC, Atrash HK, Yusuf HR, Boulet SL. Is polycystic ovary syndrome another risk factor for venous thromboembolism? United States, 2003-2008. Am J Obstet Gynecol 2012;207:377.e1-377.e8.
    • (2012) Am J Obstet Gynecol , vol.207 , Issue.377
    • Okoroh, E.M.1    Hooper, W.C.2    Atrash, H.K.3    Yusuf, H.R.4    Boulet, S.L.5
  • 64
    • 77955924407 scopus 로고    scopus 로고
    • Risk of venous thrombosis with oral versus transdermal estrogen therapy among postmenopausal women
    • Olie V.,Canonico M.,Scarabin P.Y.;Risk of venous thrombosis with oral versus transdermal estrogen therapy among postmenopausal women:Curr Opin Hematol:2010:17;457-463.
    • (2010) Curr Opin Hematol , vol.17 , pp. 457-463
    • Olie, V.1    Canonico, M.2    Scarabin, P.Y.3
  • 66
    • 0028324624 scopus 로고
    • Thrombotic risk of women with hereditary antithrombin III-, protein C- and protein S-deficiency taking oral contraceptive medication. The GTH Study Group on Natural Inhibitors
    • Pabinger I, Schneider B. Thrombotic risk of women with hereditary antithrombin III-, protein C- and protein S-deficiency taking oral contraceptive medication. The GTH Study Group on Natural Inhibitors. Thromb Haemost 1994;71: 548-552.
    • (1994) Thromb Haemost , vol.71 , pp. 548-552
    • Pabinger, I.1    Schneider, B.2
  • 67
    • 40949151066 scopus 로고    scopus 로고
    • Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study
    • Pomp ER, Lenselink AM, Rosendaal FR, Doggen CJ. Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study. J Thromb Haemost 2008;6:632-637.
    • (2008) J Thromb Haemost , vol.6 , pp. 632-637
    • Pomp, E.R.1    Lenselink, A.M.2    Rosendaal, F.R.3    Doggen, C.J.4
  • 69
    • 84882639824 scopus 로고    scopus 로고
    • RCOG(RoyalCollege ofObstetricians andGynaecologists).
    • Green-top Guideline
    • RCOG(RoyalCollege ofObstetricians andGynaecologists). Venous thromboembolism and hormonal contraception. Green-top Guideline No. 40, 2010.
    • (2010) Venous thromboembolism and hormonal contraception , vol.40
  • 70
    • 84882588728 scopus 로고    scopus 로고
    • RCOG (Royal College of Obstetricians and Gynaecologists).
    • Green-top Guideline, 3rd edition
    • RCOG (Royal College of Obstetricians and Gynaecologists). Venous thromboembolism and hormone replacement therapy. Green-top Guideline No. 19, 3rd edition, 2011.
    • (2011) Venous thromboembolism and hormone replacement therapy , vol.19
  • 71
    • 77953573349 scopus 로고    scopus 로고
    • Hormone replacement therapy and the risk of venous thromboembolism: a population-based study
    • Renoux C, Dell'Aniello S, Suissa S. Hormone replacement therapy and the risk of venous thromboembolism: a population-based study. J Thromb Haemost 2010; 8:979-986.
    • (2010) J Thromb Haemost , vol.8 , pp. 979-986
    • Renoux, C.1    Dell'Aniello, S.2    Suissa, S.3
  • 72
  • 73
    • 0033519051 scopus 로고    scopus 로고
    • Venous thrombosis: a multicausal disease
    • Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet 1999; 353:1167-1173.
    • (1999) Lancet , vol.353 , pp. 1167-1173
    • Rosendaal, F.R.1
  • 75
    • 0035190596 scopus 로고    scopus 로고
    • A 16-year haemodynamic follow-up of women with pregnancy-related medically treated iliofemoral deep venous thrombosis
    • Rosfors S, Noren A, Hjertberg R, Persson L, Lillthors K, Torngren S. A 16-year haemodynamic follow-up of women with pregnancy-related medically treated iliofemoral deep venous thrombosis. Eur J Vasc Endovasc Surg 2001;22:448-455.
    • (2001) Eur J Vasc Endovasc Surg , vol.22 , pp. 448-455
    • Rosfors, S.1    Noren, A.2    Hjertberg, R.3    Persson, L.4    Lillthors, K.5    Torngren, S.6
  • 76
    • 84155172808 scopus 로고    scopus 로고
    • Venous thromboembolism in relation to in vitro fertilization: an approach to determining the incidence and increase in risk in successful cycles
    • Rova K, Passmark H, Lindqvist PG. Venous thromboembolism in relation to in vitro fertilization: an approach to determining the incidence and increase in risk in successful cycles. Fertil Steril 2012;97:95-100.
    • (2012) Fertil Steril , vol.97 , pp. 95-100
    • Rova, K.1    Passmark, H.2    Lindqvist, P.G.3
  • 77
    • 67650341330 scopus 로고    scopus 로고
    • Combined jugular and subclavian vein thrombosis following assisted reproductive technology- new observation
    • Salomon O, Schiby G, Heiman Z, Avivi K, Sigal C, Levran D, Dor J, Itzchak Y. Combined jugular and subclavian vein thrombosis following assisted reproductive technology- new observation. Fertil Steril 2009;92:620-625.
    • (2009) Fertil Steril , vol.92 , pp. 620-625
    • Salomon, O.1    Schiby, G.2    Heiman, Z.3    Avivi, K.4    Sigal, C.5    Levran, D.6    Dor, J.7    Itzchak, Y.8
  • 78
    • 77955875684 scopus 로고    scopus 로고
    • Hot flushes: are there effective alternatives to estrogen
    • Menopause Int
    • Sassarini J, Lumsden MA. Hot flushes: are there effective alternatives to estrogen? Menopause Int 2010;16:81-88.
    • (2010) , vol.16 , pp. 81-88
    • Sassarini, J.1    Lumsden, M.A.2
  • 79
    • 0042737410 scopus 로고    scopus 로고
    • Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk
    • Scarabin PY, Oger E, Plu-Bureau G. Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk. Lancet 2003; 362:428-432.
    • (2003) Lancet , vol.362 , pp. 428-432
    • Scarabin, P.Y.1    Oger, E.2    Plu-Bureau, G.3
  • 83
    • 24744470476 scopus 로고    scopus 로고
    • Obesity as a risk factor in venous thromboembolism
    • Stein PD, Beemath A, Olson RE. Obesity as a risk factor in venous thromboembolism. Am J Med 2005;118:978-980.
    • (2005) Am J Med , vol.118 , pp. 978-980
    • Stein, P.D.1    Beemath, A.2    Olson, R.E.3
  • 84
    • 0030764967 scopus 로고    scopus 로고
    • First-time use of newer oral contraceptives and the risk of venous thromboembolism
    • Suissa S, Blais L, Spitzer WO, Cusson J, Lewis M, Heinemann L. First-time use of newer oral contraceptives and the risk of venous thromboembolism. Contraception 1997; 56:141-146.
    • (1997) Contraception , vol.56 , pp. 141-146
    • Suissa, S.1    Blais, L.2    Spitzer, W.O.3    Cusson, J.4    Lewis, M.5    Heinemann, L.6
  • 85
    • 84868132798 scopus 로고    scopus 로고
    • The MillionWomen Study Collaborators. Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study
    • First published online October 30, 2012. doi:10.1111/j.1538-7836.2012.04919.x
    • Sweetland S, Beral V, Balkwill A, Liu B, Benson VS, Canonico M, Green J, Reeves GK., The MillionWomen Study Collaborators. Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study. J Thromb Haemost 2012;10:2277-2286. First published online October 30, 2012. doi:10.1111/j.1538-7836.2012.04919.x
    • (2012) J Thromb Haemost , vol.10 , pp. 2277-2286
    • Sweetland, S.1    Beral, V.2    Balkwill, A.3    Liu, B.4    Benson, V.S.5    Canonico, M.6    Green, J.7    Reeves, G.K.8
  • 86
    • 1142267008 scopus 로고    scopus 로고
    • The Writing Group for theWomen's Health Initiative. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative
    • The Writing Group for theWomen's Health Initiative. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative. JAMA 2002;255:3243-3253.
    • (2002) JAMA , vol.255 , pp. 3243-3253
  • 87
    • 0028029477 scopus 로고
    • Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation
    • Vandenbroucke JP, KosterT, Briet E, Reitsma PH, Bertina RM, Rosendaal FR. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 1994;344:1453-1457.
    • (1994) Lancet , vol.344 , pp. 1453-1457
    • Vandenbroucke, J.P.1    Koster, T.2    Briet, E.3    Reitsma, P.H.4    Bertina, R.M.5    Rosendaal, F.R.6
  • 88
    • 79251587186 scopus 로고    scopus 로고
    • Hormone therapies and venous thromboembolism: where are we now
    • J Thromb Haemost
    • van Hylckama Vlieg A, Middeldorp S. Hormone therapies and venous thromboembolism: where are we now? J Thromb Haemost 2011;9:257-266.
    • (2011) , vol.9 , pp. 257-266
    • van Hylckama Vlieg, A.1    Middeldorp, S.2
  • 89
    • 69949103268 scopus 로고    scopus 로고
    • The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study
    • van Hylckama Vlieg A, Helmerhorst FM, Vandenbroucke JP, Doggen CJ, Rosendaal FR. The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study. BMJ 2009; 339:b2921.
    • (2009) BMJ , vol.339
    • van Hylckama Vlieg, A.1    Helmerhorst, F.M.2    Vandenbroucke, J.P.3    Doggen, C.J.4    Rosendaal, F.R.5
  • 90
    • 78149282226 scopus 로고    scopus 로고
    • The risk of deep venous thrombosis associated with injectable depot-medroxyprogesterone acetate contraceptives or a levonorgestrel intrauterine device
    • van Hylckama Vlieg A, Helmerhorst FM, Rosendaal FR. The risk of deep venous thrombosis associated with injectable depot-medroxyprogesterone acetate contraceptives or a levonorgestrel intrauterine device. Arterioscler Thromb Vasc Biol 2010;30:2297-2300.
    • (2010) Arterioscler Thromb Vasc Biol , vol.30 , pp. 2297-2300
    • van Hylckama Vlieg, A.1    Helmerhorst, F.M.2    Rosendaal, F.R.3
  • 91
    • 64849114049 scopus 로고    scopus 로고
    • The effect of the levonorgestrel-releasing intrauterine system on the resistance to activated protein C (APC)
    • van Vliet HA, Tchaikovski SN, Rosendaal FR, Rosing J, Helmerhorst FM. The effect of the levonorgestrel-releasing intrauterine system on the resistance to activated protein C (APC). Thromb Haemost 2009;101:691-695.
    • (2009) Thromb Haemost , vol.101 , pp. 691-695
    • van Vliet, H.A.1    Tchaikovski, S.N.2    Rosendaal, F.R.3    Rosing, J.4    Helmerhorst, F.M.5
  • 92
    • 80052140272 scopus 로고    scopus 로고
    • Thrombotic risk during oral contraceptive use and pregnancy inwomenwith factorV Leiden or prothrombin mutation: a rational approach to contraception
    • van Vlijmen EF, Veeger NJ, Middeldorp S, Hamulyak K, Prins MH, Buller HR, Meijer K. Thrombotic risk during oral contraceptive use and pregnancy inwomenwith factorV Leiden or prothrombin mutation: a rational approach to contraception. Blood 2011; 118:2055-2061.
    • (2011) Blood , vol.118 , pp. 2055-2061
    • van Vlijmen, E.F.1    Veeger, N.J.2    Middeldorp, S.3    Hamulyak, K.4    Prins, M.H.5    Buller, H.R.6    Meijer, K.7
  • 97
    • 84866236261 scopus 로고    scopus 로고
    • Detection of a procoagulable state during controlled ovarian hyperstimulation for in vitro fertilization with global assays of haemostasis
    • Westerlund E, Henriksson P, WallenH, Hovatta O, Wallberg KR, Antovic A. Detection of a procoagulable state during controlled ovarian hyperstimulation for in vitro fertilization with global assays of haemostasis. Thromb Res 2012;130:649-653.
    • (2012) Thromb Res , vol.130 , pp. 649-653
    • Westerlund, E.1    Henriksson, P.2    Wallen, H.3    Hovatta, O.4    Wallberg, K.R.5    Antovic, A.6
  • 98
    • 84882632327 scopus 로고    scopus 로고
    • WHO (World Health Organization).
    • Geneva:World Health Organization, 4th edn
    • WHO (World Health Organization). Medical eligibility criteria for contraceptive use, 4th edn. Geneva:World Health Organization, 2011.
    • (2011) Medical eligibility criteria for contraceptive use
  • 99
    • 0031855374 scopus 로고    scopus 로고
    • A randomized controlled double-blind study of the effects on hemostasis of two progestogen-only pills containing 75mg desogestrel or 30mg levonorgestrel
    • Winkler UH, Howie H, Buhler K, Korver T, Geurts TBP, Coelingh Bennink HJT. A randomized controlled double-blind study of the effects on hemostasis of two progestogen-only pills containing 75mg desogestrel or 30mg levonorgestrel. Contraception 1998;57:385-392.
    • (1998) Contraception , vol.57 , pp. 385-392
    • Winkler, U.H.1    Howie, H.2    Buhler, K.3    Korver, T.4    Geurts, T.B.P.5    Coelingh Bennink, H.J.T.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.